Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Methodological quality assessment and analysis of influencing factors in systematic reviews of patient preference: A meta-research and evidence mapping study.

Created on 06 Nov 2026

Authors

Le Shu, Juan Ling, Ge Zhang, WenLong Xin, YanFei Li, Demián Glujovsky, Deng HongYong, YongLin Liang

Published in

Journal of clinical epidemiology. Pages 112578. Nov 05, 2026. Epub Nov 05, 2026.

Abstract

To appraise the methodological quality of systematic reviews (SRs) of adult patient preferences and to map the factors reported to influence those preferences.
We conducted a meta-research study (methodological umbrella review) with evidence mapping. We searched nine databases (PubMed, Embase, Cochrane Database of Systematic Reviews, Campbell Library, Web of Science, CBM, WanFang Data, CNKI, and CQVIP) from inception to 10 April 2026 for English- or Chinese-language SRs that directly elicited preferences from adults; screening and data extraction were performed independently in duplicate, and methodological quality was assessed using AMSTAR 2.
We included 110 SRs. Most SRs focused primarily on treatment/management (80.0%), and cancer was the most common disease field (27.3%). Methodological quality was predominantly critically low or low: 78 SRs (70.9%) were rated critically low, 28 (25.5%) low, 3 (2.7%) moderate, and 1 (0.9%) high. We mapped 17 factors reported to influence patient preferences; the most frequently reported were efficacy (67.3%), risk of adverse effects/complications (65.5%), cost (50.0%), ease and frequency of application (39.1%), and physician experience or recommendation (31.8%). Topic categories were based on each SR's primary focus and are not mutually exclusive conceptually.
Methodological quality was predominantly critically low or low (96.4%); only one SR was rated high. The evidence map identified 17 frequently reported factors and showed that evidence was concentrated in treatment/management and cancer, with limited coverage of several other disease fields. Future SRs should strengthen protocol registration, search reproducibility, duplicate screening and data extraction, risk-of-bias assessment, and transparent reporting.

PMID:
42988278
Bibliographic data and abstract were imported from PubMed on 06 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement